期刊文献+

双特异性单克隆抗体在肿瘤治疗方面的研究进展

下载PDF
导出
摘要 双特异性单克隆抗体(BsMcAb)可介导肿瘤效应物(化学药、细胞因子和细胞毒细胞)至肿瘤部位,杂交-杂交瘤BsMcAb可克服化学交联法对抗体和药物的损害,并且性质稳定、不易脱落、还有浓集效应,并可诱导、增强细胞毒细胞的杀伤性,导向作用和治疗作用强,副作用较小,是肿瘤导向治疗的新方法。
作者 汪厚平
出处 《国外医学(预防.诊断.治疗用生物制品分册)》 1995年第6期251-254,共4页 Foreign Medical Sciences(Section of Bilogics for Prophylaxis,Diagnosis and Therapy)
  • 相关文献

参考文献5

  • 1Daniele Morelli,Alessandro Sardini,Elena Villa,Maria Luisa Villa,Sylvie Ménard,Maria I. Colnaghi,Andrea Balsari. Modulation of drug-induced cytotoxicity by a bispecific monoclonal antibody that recognizes the epidermal growth factor receptor and doxorubicin[J] 1994,Cancer Immunology Immunotherapy(3):171~177
  • 2W. Smith,V. A. Gore,D. R. Brandon,D. N. Lynch,S. A. Cranstone,J. R. F. Corvalan. Suppression of well-established tumour xenografts by a hybrid-hybrid monoclonal antibody and vinblastine[J] 1990,Cancer Immunology Immunotherapy(3):157~163
  • 3J. R. F. Corvalan,W. Smith. Construction and characterisation of a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids[J] 1987,Cancer Immunology Immunotherapy(2):127~132
  • 4J. R. F. Corvalan,W. Smith,V. A. Gore,D. R. Brandon. Specific in vitro and in vivo drug localisation to tumour cells using a hybrid-hybrid monoclonal antibody recognising both carcinoembryonic antigen (CEA) and vinca alkaloids[J] 1987,Cancer Immunology Immunotherapy(2):133~137
  • 5J. R. F. Corvalan,W. Smith,V. A. Gore,D. R. Brandon,P. J. Ryde. Increased therapeutic effect of vinca alkaloids targeted to tumour by a hybrid-hybrid monoclonal antibody[J] 1987,Cancer Immunology Immunotherapy(2):138~143

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部